🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Enjoyed the time in 🇰🇷 for #ENDO2024! Honoured to receive the WEO best abstract award on behalf of our research team! 🏆

Patients with covert HE has a higher probability of developing overt HE than patients with other causes of neurocognitive impairment (NI). Read the full paper by Sultanik et al 'open access' at bit.ly/45XWiNP #GItwitter

Van Gogh-like 2 is essential for the architectural patterning of the mammalian biliary tree Full text here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Published open access at bit.ly/3S9Emdz "Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD" #GIwitter

Important paper 🚨 👇🏻!!!

"Prevalence and prognosis of patients with MASLD-related cirrhosis after an ICU hospitalization in France: A single-centre prospective study" available open access at bit.ly/46hBW2f #livertwitter

REVIEW Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction–associated steatotic liver disease Qi et al. ​​#LiverX Rohit Loomba tinyurl.com/297a6kt6

Possibly the most satisfying achievement for physician-scientists: When your proposal stands the test of time & defines clinical practice. 👉 The Baveno Cooperation: an EASL Consortium for cACLD after HCV-cure ➡️ EASLnews Position Paper 🔗 bit.ly/3Va2uh2 Journal of Hepatology 🫶 @GeorgSemmler Sabela Lens García

Excited to share our new review: "Food inequity and insecurity and MASLD: burden, challenges, and interventions" nature.com/articles/s4157…, led by Shira zelber sagi, with Juan M Pericas and more! Nature Reviews Gastroenterology & Hepatology #LiverTwitter

🆕Article in press❕ Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

👋#LiverTwitter What is your diagnosis❓ 41yo woman: dark urine, scleral icterus, fatigue, shortness of breath, RUQ pain ➡️AST 364U/L ➡️ALT 393U/L ➡️ALP 155U/L ➡️Bilirubin 9.2 mg/dl ➡️Progestin-only OCP 7wks prior History of photosensitivity Case🔗bit.ly/3XvVpsg

Great new #GUTVideo by Su et al on "Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase" via bit.ly/3AVAIOA Paper via: bit.ly/4fRTVRh The Chinese University of Hong Kong - CUHK CUHK Medicine

Achieving SVR doesn’t mean you’re free from liver cancer. The new AI-Safe-C score can identify patients at residual cancer risk. Stay informed! Congratulations, Huapeng! #Hepatology #LiverCancer #AI journal-of-hepatology.eu/article/S0168-…

This is probably the first MetALD Conference ever. Thank you, Rohit Loomba, for hosting this in San Diego! metaldconference.org

Call for abstracts for the MetALD Conference in San Diego Nov 14 at Westin Gaslamp Quarter- A star-studded panel of faculty from over 25 institutions worldwide - Vincent Wong Marco Arrese, MD Quentin M. Anstee Daniel Huang Juan Pablo (JP) Arab, MD  Michael Charlton MD, FRCP metaldconference.org/agenda #livertwitter

A new blood-based biomarker for #MASH has been confirmed in diverse US and Chinese populations. Amazing collaboration among CUHK Medicine, UC San Diego Health, and Wenzhou Medical University! Read more in Cell Metabolism: sciencedirect.com/science/articl…

1: In 2025, look out for a new section in Journal of Hepatology:  "Breakthroughs Beyond the Journal". Editorial-style analyses of pivotal liver research 2: My comment on work from Cell Metabolism showing that MI drives #MASH. The interaction between these two diseases works BOTH ways 👇

EASLnews Aleksander Krag Sven Francque APDP Diabetes Paul Brennan Maja Thiele Jörn Schattenberg Naim Alkhouri Maru Rinella MD FattyLiverAlliance Francesco Paolo Russo Ajay Duseja Arun J. Sanyal @HannesHagstrom Ramon Bataller ELISA POSE Luis Antonio Díaz, MD Brett E Fortune MD Alina Allen Mads Israelsen Tom Hemming Karlsen Mazen Noureddin, MD, MHSc Melina Manolas, MD, MPH Manuel Romero-Gómez Javier Crespo FDA Jordi Gracia-Sancho Juan Pablo (JP) Arab, MD  Javier Ampuero Juan M Pericas AASLD American Gastroenterological Association (AGA) Luca Valenti Shira zelber sagi European Liver Patients' Association Scott Isaacs Elliot Tapper EASO World Obesity Joaquin Cabezas Jose Luis Calleja Liver Patients International (LPI) LiverAim Salvatore Piano Prof Shira zelber sagi presenting "Food inequity and insecurity and MASLD: burden, challenges, and interventions." We need to up our collaboration game and breakdown silos: nature.com/articles/s4157… Nature Reviews Gastroenterology & Hepatology #SLDsummit

What’s the best way to implement the 2-step clinical care pathway for evaluating MASLD? Is it as effective as VCTE for all patients? Check out this paper in J Hep: authors.elsevier.com/sd/article/S01…. Congrats to Terry Cheuk-Fung Yip and the VCTE-Prognosis Study Team! 🎉 #MASLD #ClinicalResearch

New study at Journal of Hepatology unveils how two-step clinical care pathway for #MASLD predicts #MALOs. Many thanks to all collaborators! Explore our latest #VCTE-Prognosis Study: shorturl.at/wBeSM! Vincent Wong Grace Wong CUHK Medicine CUHK Gastroenterology & Hepatology